BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukocyte
,
Pharmacogenetics
,
Quercetin
,
rs2476601
,
KLK3
,
Apoptosis
,
Breast Cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MD-2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
buparvaquone
Trenbolone Acetate, (17beta)-isomer
Estradiol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Airway epithelial BEAS-2 cells with control or LY96 siRNA treated with house dust mite extract
Explore Curated Studies Results
Literature
Most Relevant Literature
MD-2 binds cholesterol.
sTLR4/MD-2 complex inhibits colorectal cancer migration and invasiveness in vitro and in vivo by lnc…
Therapeutic implication of 'Iturin A' for targeting MD-2/TLR4 complex to overcome angiogenesis and i…
Determination of the binding mode for anti-inflammatory natural product xanthohumol with myeloid dif…
Molecular Basis of the Functional Differences between Soluble Human Versus Murine MD-2: Role of Val1…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts…
G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Under…
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML an…
Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ